Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

202.92B

Market cap202.92B

Price-Earnings ratio

11.04

Price-Earnings ratio11.04

Dividend yield

2.61%

Dividend yield2.61%

Average volume

16.80M

Average volume16.80M

High today

$47.49

High today$47.49

Low today

$46.73

Low today$46.73

Open price

$47.17

Open price$47.17

Volume

11.87M

Volume11.87M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Simply Wall St 17h

Novo Nordisk Faces A Fair Value Debate, Is It Still 55% Undervalued?

Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against...

Simply Wall St 23h

Novo Nordisk (CPSE:NOVO B) Blocks Unapproved Semaglutide Nasal Spray In Dutch Court - simplywall.st

...

TipRanks 1d

Retail Investors Send in Sick Note for HIMS Stock Ahead of Q2 Earnings

Retail investors are feeling less healthy about the prospects of Hims & Hers (HIMS) as it gets set to report Q2 earnings next week – August 10th. Unlock powerf...

Analyst ratings

54%

of 37 ratings

Buy

37.8%

Hold

54.1%

Sell

8.1%

More NVO News

Benzinga 1d

Novo Nordisk Scores Major Court Win, Dutch Judge Halts Compounded Semaglutide Nasal Spray

Dutch judges have issued a preliminary injunction against a European compounding firm, forcing an immediate halt to sales of an unauthorized semaglutide nasal s...

CNBC 1d

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Key Points Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. But while investors cheered Lilly's results, they...

TipRanks 1d

Novo Nordisk price target raised to $47 from $45 at BMO Capital

BMO Capital analyst Evan Seigerman raised the firm’s price target on Novo Nordisk (NVO) to $47 from $45 and keeps a Market Perform rating on the shares. Novo No...

Seeking Alpha 1d

Amazon delivers GLP-1s for $50 per month for Medicare recipients

Amazon Pharmacy (AMZN) has joined a federal program to offer GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) to eligible Medicare enrollees...

Simply Wall St 2d

Novo Nordisk Stock May Be Below Fair Value On ZEUS Trial Fallout

After a three year stretch where Novo Nordisk stock has declined 50.5%, the valuation picture now looks more supportive than the share price performance suggest...

CNBC 2d

We're increasing our Eli Lilly price target after another beat-and-raise quarter

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company's portfolio of GLP-1 drugs continues to...

MarketWatch 2d

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

In August 2024, Novo Nordisk bused its employees to the sprawling Roskilde fairgrounds outside Copenhagen for its annual summer party. The Danish company had ho...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.